- UK tech funding roundup: This week’s deals from Monzo to Haiper
- Funding rounds for Monzo, Phagenesis, Haiper, and more in the UK tech industry
- Monzo offers digital banking services, Phagenesis focuses on treating swallowing dysfunction
- Haiper is a generative AI video startup, Wobble Genomics speeds up drug development
- Other startups like Fluent, Theia Insights, Cogna, and Gridcog receive funding in various sectors
Monzo Secures Late VC Funding
In the latest UK tech funding roundup, digital banking giant Monzo made headlines by securing late VC funding from top investors such as CapitalG, Google Ventures, Passion Capital, Tencent, and HongShan Capital. Founded in 2015, Monzo has been revolutionizing the banking industry with its innovative approach to digital banking services, offering consumer and business current and savings accounts, investing, and loans. The significant investment from these renowned investors highlights the confidence in Monzo’s growth potential and its impact on the fintech sector.
Phagenesis Raises Series D Funding for Health Tech Innovation
Another notable development in the UK tech funding landscape is the Series D funding round secured by health tech firm Phagenesis. With investors including British Patient Capital, EQT Life Sciences, Sectoral, Northern Gritstone, and Aphelion, Phagenesis is poised to advance its neurostimulation system for treating swallowing dysfunction, a common issue resulting from brain injuries. The funding will enable Phagenesis to further develop its innovative healthcare technology and expand its reach to help more patients in need.
Haiper Introduces Generative AI Video Tool with Seed Funding
London-based AI startup Haiper entered the scene with its seed funding round led by Octopus Ventures. Founded in 2021, Haiper offers a generative AI tool that creates short videos based on user prompts, catering to the growing demand for AI-driven content creation solutions. The investment in Haiper highlights the potential of AI technology in the video production space and positions the company for rapid growth and innovation in the AI sector.
Related Video
Wobble Genomics Gains Pre-Series A Funding for Biotech Advancements
Edinburgh-based health tech startup Wobble Genomics secured pre-Series A funding from investors such as Mercia Ventures, BGF, IQ Capital, EOS Advisors, and the University of Edinburgh. Founded in 2021, Wobble Genomics focuses on developing RNA sequencing technology aimed at accelerating drug development processes. The funding will support Wobble Genomics in its mission to revolutionize biotech research and enhance the efficiency of drug discovery efforts.
The UK tech funding landscape continues to showcase a diverse range of innovative startups and established players securing significant investments to drive growth, innovation, and impact across various sectors. With a mix of fintech, health tech, AI, climate tech, and cybersecurity companies attracting funding from prominent investors, the UK remains a vibrant hub for tech innovation and entrepreneurship.
Links to additional Resources: 1. https://www.monzo.com/ 2. https://www.phagenesis.com/ 3. https://www.haiper.ai/